JP2019511465A5 - - Google Patents

Download PDF

Info

Publication number
JP2019511465A5
JP2019511465A5 JP2018542140A JP2018542140A JP2019511465A5 JP 2019511465 A5 JP2019511465 A5 JP 2019511465A5 JP 2018542140 A JP2018542140 A JP 2018542140A JP 2018542140 A JP2018542140 A JP 2018542140A JP 2019511465 A5 JP2019511465 A5 JP 2019511465A5
Authority
JP
Japan
Prior art keywords
dry suspension
weight
suspension
polymorph
simethicone
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2018542140A
Other languages
English (en)
Japanese (ja)
Other versions
JP7074677B2 (ja
JP2019511465A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2017/017915 external-priority patent/WO2017142910A1/en
Publication of JP2019511465A publication Critical patent/JP2019511465A/ja
Publication of JP2019511465A5 publication Critical patent/JP2019511465A5/ja
Priority to JP2021201709A priority Critical patent/JP7297858B2/ja
Application granted granted Critical
Publication of JP7074677B2 publication Critical patent/JP7074677B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2018542140A 2016-02-16 2017-02-15 Ｓｔ－２４６（テコビリマット一水和物）懸濁製剤 Active JP7074677B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2021201709A JP7297858B2 (ja) 2016-02-16 2021-12-13 Ｓｔ－２４６（テコビリマット一水和物）懸濁製剤

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662295710P 2016-02-16 2016-02-16
US62/295,710 2016-02-16
PCT/US2017/017915 WO2017142910A1 (en) 2016-02-16 2017-02-15 St-246 ( tecovirimat monohydrate) suspension formulations

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2021201709A Division JP7297858B2 (ja) 2016-02-16 2021-12-13 Ｓｔ－２４６（テコビリマット一水和物）懸濁製剤

Publications (3)

Publication Number Publication Date
JP2019511465A JP2019511465A (ja) 2019-04-25
JP2019511465A5 true JP2019511465A5 (enExample) 2020-03-26
JP7074677B2 JP7074677B2 (ja) 2022-05-24

Family

ID=59625432

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2018542140A Active JP7074677B2 (ja) 2016-02-16 2017-02-15 Ｓｔ－２４６（テコビリマット一水和物）懸濁製剤
JP2021201709A Active JP7297858B2 (ja) 2016-02-16 2021-12-13 Ｓｔ－２４６（テコビリマット一水和物）懸濁製剤

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2021201709A Active JP7297858B2 (ja) 2016-02-16 2021-12-13 Ｓｔ－２４６（テコビリマット一水和物）懸濁製剤

Country Status (8)

Country Link
US (2) US11433051B2 (enExample)
EP (1) EP3416637A4 (enExample)
JP (2) JP7074677B2 (enExample)
CN (1) CN108430469A (enExample)
AU (2) AU2017221295B2 (enExample)
CA (1) CA3013937A1 (enExample)
IL (1) IL260229B2 (enExample)
WO (1) WO2017142910A1 (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2017221295B2 (en) * 2016-02-16 2022-05-19 Siga Technologies, Inc. ST-246 ( Tecovirimat monohydrate) suspension formulations
WO2018049184A1 (en) 2016-09-09 2018-03-15 Cutispharma, Inc. Suspensions and diluents for metronidazole and baclofen
CN115141136B (zh) * 2021-03-31 2023-06-20 中国人民解放军军事科学院军事医学研究院 特考韦瑞药的共晶及其制备方法
JP7546138B2 (ja) * 2021-12-21 2024-09-05 上海奥全生物医葯科技有限公司 固形剤形を水に分散させて懸濁液を形成する方法、懸濁液および固体剤形を投与する方法
CN116625971A (zh) * 2023-04-11 2023-08-22 北京达因高科儿童药物研究院有限公司 一种西甲硅油口溶膜中二甲硅油和二氧化硅含量的检测方法

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3043747A (en) * 1958-10-22 1962-07-10 Upjohn Co Tablets coated with carboxymethylcellulose shellac composition
US4863737A (en) * 1985-05-01 1989-09-05 University Of Utah Compositions and methods of manufacture of compressed powder medicaments
ES2043766T3 (es) * 1987-11-11 1994-01-01 Pharmascience Lab Una nueva composicion farmaceutica que comprende exifona y un polimero soluble en agua.
FR2705966B1 (fr) * 1993-06-04 1995-08-25 Dow Corning Sa Compositions antimousse utiles notamment pour le traitement de troubles gastriques.
CN100571683C (zh) * 2007-02-05 2009-12-23 深圳致君制药有限公司 干混悬剂及其制备方法
CA2793533C (en) 2010-03-23 2019-02-26 Siga Technologies, Inc. Polymorphic forms of st-246 and methods of preparation
CN102532901A (zh) 2010-12-21 2012-07-04 重庆北碚现代应用药物研究所 一种西甲硅油的制备方法
CN102406617B (zh) * 2011-11-30 2013-08-28 中国人民解放军军事医学科学院生物工程研究所 一种替韦立马干混悬剂及其制备方法
CN105055326B (zh) 2015-07-17 2018-02-06 西南大学 西甲硅油干混悬剂及其制备方法
AU2017221295B2 (en) * 2016-02-16 2022-05-19 Siga Technologies, Inc. ST-246 ( Tecovirimat monohydrate) suspension formulations

Similar Documents

Publication Publication Date Title
JP2019511465A5 (enExample)
JP4827915B2 (ja) リファキシミンを含む胃抵抗性薬剤組成物
JP5128948B2 (ja) 癌の治療のための新規な薬剤組成物
KR101257918B1 (ko) 콜린 알포세레이트 또는 이의 약학적으로 허용되는 염을 포함하는 서방형 약학 조성물 및 이의 제조방법
IL260229B2 (en) Suspension formulations of st-246 (tecovirimate monohydrate)
CN107530292B (zh) 瑞博西尼片剂
KR101257919B1 (ko) 콜린 알포세레이트 또는 이의 약학적으로 허용되는 염을 포함하는 경구용 고형 제제 및 이의 제조방법
WO1998042311A1 (en) Gastrointestinal mucosa-adherent pharmaceutical composition
JP2009502835A (ja) レベチラセタムを含む薬剤組成物及びその調製方法
JP2011503017A (ja) ヒドロモルホン含有徐放性錠剤
CN103118666A (zh) 含有利福昔明的药物制剂、制备其的方法和治疗肠疾病的方法
CN105377256A (zh) 低剂量药物组合物
JP2020518611A (ja) 水溶解度及びバイオアベイラビリティが改善された組成物
US20150366807A1 (en) Oral pharmaceutical composition comprising dabigatran etexilate
JP2013006798A (ja) 粒子製剤の製造方法
KR20120094178A (ko) 레바프라잔-함유 나노입자를 포함하는 경구투여용 약학 조성물 및 그의 제조방법
WO2015145157A1 (en) Pharmaceutical composition comprising pazopanib
EP2723322A1 (en) Imatinib mesylate oral pharmaceutical composition and process for preparation thereof
CN108078936B (zh) 马来酸曲美布汀分散片及其制备方法
EP3397285B1 (en) Tablet formulations of montelukast sodium and rupatadine fumarate
CA2984235C (en) Rivastigmine-containing sustained-release pharmaceutical composition
JP2023127913A (ja) ベンラファキシン塩酸塩含有顆粒
CN119604285A (zh) Protac化合物的药物组合物及其用途
JP6824816B2 (ja) 口腔内崩壊性被覆錠剤及び口腔内崩壊性被覆錠剤の被覆層用組成物
JP2010516712A5 (enExample)